Baotou Tianhe Magnetics Technology
603072
HuangShan Googe
301581
Geovis Insighter Technology
920116
CHICHENG ELECTRIC
834407
Xdc Industries(Shenzhen)Limited
300615
CN Stock MarketDetailed Quotes
002898 Sailong Pharmaceutical Group
- 9.11
- -0.41-4.31%
Market Closed Jan 3 15:00 CST
1.60BMarket Cap1012.22P/E (TTM)
9.58High9.08Low31.76KlotVolume9.52Open9.52Pre Close29.54MTurnover3.14%Turnover Ratio168.70P/E (Static)176.00MShares14.0552wk High3.03P/B922.50MFloat Cap7.6852wk Low10.47Limit Up101.26MShs Float30.73Historical High8.57Limit Down5.25%Amplitude7.42Historical Low0.02Dividend TTM9.30Avg Price18.36KlotAsk0.22%Div YieldTTM100Lot Size12.07KlotBid
Sailong Pharmaceutical Group News
Sailong Pharmaceutical: Announcement on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Sailong Pharmaceutical: Announcement on changing the signed certified public accountant
Sailong Pharmaceutical: Announcement on participating in the tenth batch of centralized national drug procurement and planning to win the bid
Sailong Pharmaceutical: Announcement on the subsidiary obtaining a notice of approval for the marketing application of chemical raw materials
Sailong Pharmaceutical: Announcement on cancellation of pledges for shareholders\' shares holding 5% or more
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for esprolol hydrochloride injection
Cailong Pharmaceutical: Announcement on the subsidiary obtaining a fluorouracil injection drug registration certificate
Sailong Pharmaceutical: Announcement on the expiration of the share reduction plan for shareholders holding 5% or more of the shares
Sailong Pharmaceutical: Announcement on the Wholly-owned Subsidiary Obtaining the “Notice of Approval of the Drug Supplement Application”
Sailong Pharmaceutical: Announcement on changes in equity of shareholders holding 5% or more of the shares to 1%
Sailong Pharmaceutical: Announcement on preparation for impairment calculation for the first three quarters of 2024
Cailong Pharmaceutical: Announcement of Board Resolutions
Sailong Pharmaceutical: Review Opinions of the Third Meeting of the Fourth Board Audit Committee in 2024
Sailong Pharmaceutical: Explanation of the Supervisory Board on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceuticals: Report for the third quarter of 2024
Cailong Pharmaceutical: Announcement of Supervisory Board Resolutions
Sailong Pharmaceutical: Explanation of the Board of Directors and Audit Committee on the reasonableness of the company\'s impairment preparations
Cailong Pharmaceutical: Announcement on the Election of the Chairman of the Supervisory Board
Sailong Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Fourth Board of Supervisors
Sailong Pharmaceutical: Legal Opinion on the 2024 Fourth Extraordinary General Meeting of Shareholders of Sailong Pharmaceutical Group Co., Ltd.
